dalteparin has been researched along with Buruli Ulcer Disease in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kouame, K | 1 |
| Ecra, E | 1 |
| Cisse, M | 1 |
| Gbery, I | 1 |
| Kacou, E | 1 |
| Kassi, K | 1 |
| Kouassi, A | 1 |
| Ahogo, C | 1 |
| Yoboue, P | 1 |
| Kanga, JM | 1 |
1 other study available for dalteparin and Buruli Ulcer Disease
| Article | Year |
|---|---|
[Buruli ulcer involving the head: outcomes and therapeutic aspects in 8 cases observed at the University Hospital Center in Abidjan, Cote d'Ivoire].
Topics: Adolescent; Anti-Bacterial Agents; Anticoagulants; Buruli Ulcer; Child; Child, Preschool; Cote d'Ivo | 2008 |